Status:
UNKNOWN
Identifying Methylation Biomarkers for Monitoring Bladder Tumors
Lead Sponsor:
Copenhagen University Hospital at Herlev
Conditions:
Bladder Cancer
Eligibility:
All Genders
18+ years
Brief Summary
To investigate the methylation status of 4-6 genes in Urine and matching bladder tissue biopsies, in order to find methylation markers for use in a noninvasive test in monitoring patients with bladder...
Eligibility Criteria
Inclusion
- Patients with bladder tumors and patients with benign urinary tract conditions with no clinical suspicion of bladder cancer.
Exclusion
- Patients with competing urinary and systemic diseases, pregnant and patients under 18 years of age.
Key Trial Info
Start Date :
November 1 2005
Trial Type :
OBSERVATIONAL
End Date :
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT00244205
Start Date
November 1 2005
Last Update
November 15 2005
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Copenhagen University Hospital at Herlev
Herlev, Copenhagen, Denmark, 2730